Surajit Karmakar
19PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (19)
Sort by Publication Date:
|Mar 10, 2026
Acetylated Nanoformulation of N-(4-Hydroxyphenyl)-4-Oxoretinamide Inhibits EZH2-Mediated Epigenetic Repression in Neuroblastoma.Boddu Mrunalini, Atul Dev, Surajit Karmakar
|Jan 14, 2026
Chitosan-based nanoparticles for targeted delivery of 17β-estradiol to enhance SIRT1-mediated autophagy and mitigate rotenone-induced Parkinson's disease.Liku Biswal, Mohd Ayoub, Devangi Ghosh
|Dec 23, 2024
Bone-Marrow-Targeted Nanocomposite Abrogates C-Myb-Survivin Cross Talk in MLL-AF9-Rearranged Acute Myeloid Leukemia in In Vitro and In Vivo Patient-Derived Xenograft Models.Avinash Chandra Kushwaha, Boddu Mrunalini, Pankaj Malhotra
|Aug 01, 2024
Encapsulation of 4-oxo-N-(4-hydroxyphenyl) retinamide in human serum albumin nanoparticles promotes EZH2 degradation in preclinical neuroblastoma models.Boddu Mrunalini, Atul Dev, Avinash Chandra Kushwaha
|Feb 12, 2024
Melatonin-Loaded Nanoparticles Augment Mitophagy to Retard Parkinson's Disease.Liku Biswal, Mohammed Nadim Sardoiwala, Avinash Chandra Kushwaha
|Dec 18, 2023
FTY720 Nanoformulation Induces O-GlcNacylation of Synuclein to Alleviate Synucleinopathy.Mohammed Nadim Sardoiwala, Mrunalini Boddu, Liku Biswal
Pageof 4
